Uncovering functional variants using a high-efficiency PE3-based screening platform
Science Advances · 05.06.2026 · 12 (23)
DOI: 10.1126/sciadv.ady7359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.06.2026. Verfasst von Shisheng Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical Uni…. Hauptthemen laut MEDLINE: High-Throughput Screening Assays. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Prime editing (PE) enables precise nucleotide changes but has limited utility in high-throughput functional screening due to low editing efficiency. Here, we developed EvoPRIME, a PE3-based screening platform that integrates Csy4-mediated processing of Pol II–driven guide RNAs with a fluorescence-based enrichment strategy. EvoPRIME achieves comparable efficiency to state-of-the-art prime editing systems without requiring mismatch repair (MMR) suppression. We validated the performance of EvoPRIME through a loss-of-function (LOF) dropout screen targeting essential genes, which showed improved sensitivity and reproducibility, and a gain-of-function (GOF) saturation mutagenesis screen of the EGFR tyrosine kinase domain under osimertinib selection, which identified both known and uncharacterized resistance-conferring mutations. Leveraging EvoPRIME, we further conducted a high-throughput screen that functionally assesses both gain- and loss-of-phosphorylation (GOP and LOP) mutations. Among the hits, GAB1 S419E emerged as a phosphomimetic mutation that activates AKT signaling and confers osimertinib resistance. These studies establish EvoPRIME as a versatile platform for uncovering functional variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu 213003, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
- Department of lmmunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- The Key Laboratory of Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200237, China.
ORCID-Profile: Shisheng Huang, Wanyu Tao, Xiangyang Li, Yu Zhang, Gaoyang Li, Gaofeng Fan, Shang-Min Zhang, Xingxu Huang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Huang, S., Tao, W., Li, X., Guo, J., Zhang, Y., Li, G., Zhang, P., Zhang, G., Li, G., Fan, G., Zhang, S. M., & Huang, X. (2026). Uncovering functional variants using a high-efficiency PE3-based screening platform. Science Advances, 12(23). https://doi.org/10.1126/sciadv.ady7359
Vancouver
Huang S, Tao W, Li X, Guo J, Zhang Y, Li G, et al. Uncovering functional variants using a high-efficiency PE3-based screening platform. Science Advances. 2026;12(23). doi:10.1126/sciadv.ady7359
BibTeX
@article{Huang2026,
author = {Huang, Shisheng and Tao, Wanyu and Li, Xiangyang and Guo, Junfan and Zhang, Yu and Li, Guanglei and Zhang, Pengfei and Zhang, Guiquan and Li, Gaoyang and Fan, Gaofeng and Zhang, Shang-Min and Huang, Xingxu},
title = {Uncovering functional variants using a high-efficiency PE3-based screening platform},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {23},
doi = {10.1126/sciadv.ady7359}
}
EUVIMED